FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for AMNESTEEM (isotretinoin) filed by Mylan Pharmaceuticals Inc., resulting in a label update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)